VERRICA PHARMACEUTICALS INC (VRCA)

US92511W1080 - Common Stock

6.87  +0.22 (+3.31%)

After market: 6.87 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
5.12M9.03M12.00M0.000.00
Cost Of Goods
746.00K730.00KN/AN/AN/A
Gross Profit
4.38M8.31MN/AN/AN/A
Operating Expenses
67.60M29.60M42.91M40.18M30.08M
Research and Development
20.30M12.20M15.93M15.67M15.44M
Selling, General, and Administrative Expenses
47.30M17.41M26.98M24.51M14.64M
Operating Income
-63.22M-21.29M-30.91M-40.18M-30.08M
Interest Income/Expense
-1.22M-1.70M-4.17M-2.51M1.88M
Other Income/Expense
-14.00K-60.00KN/A0.000.00
Non Recurring Items
-2.54M-1.44MN/AN/AN/A
Income Before Taxes
-67.00M-24.49M-35.08M-42.69M-28.21M
Income Tax
N/A0.00N/AN/AN/A
Net Income
-67.00M-24.49M-35.08M-42.69M-28.21M
EBITDA
-62.67M-20.84M-30.67M-40.14M-30.02M
 
Per Share Data
EPS Diluted Total Ops
-1.48-0.72-1.30-1.71-1.13
Non GAAP EPS
-1.46-0.79-1.29-1.71-1.13
 
Statistics
Gross Profit Margin
85.44%92.03%N/AN/AN/A
Profit Margin
-1307.47%-271.21%-292.33%N/AN/A
Operating Profit Margin
-1233.84%-235.77%-257.58%N/AN/A

All data in USD

Charts